Fig. 3.

a Pancreatic uptake of [¹¹¹In]exendin in C57Bl/6 mice (n = 2) on different days after alloxan treatment (50 mg/kg). b Pancreatic uptake of [¹¹¹In]exendin in C57Bl/6 mice treated with vehicle (control) (n = 2) and 50 mg/kg alloxan (n = 2). Blocking was performed by coinjection of 25 μg unlabeled exendin (n = 1). c Autoradiography of pancreatic sections of C57Bl/6 mice treated with vehicle (control) and 50 mg/kg alloxan. Blocking was performed by coinjection of 25 μg unlabeled exendin.